4//SEC Filing
Burgess Paul D. 4
Accession 0000950170-23-039165
CIK 0001805387other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 5:11 PM ET
Size
5.1 KB
Accession
0000950170-23-039165
Insider Transaction Report
Form 4
Burgess Paul D.
See Remarks
Transactions
- Purchase
Common Stock
2023-08-04$22.93/sh+21,880$501,794→ 21,880 total
Footnotes (1)
- [F1]The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.85 - $22.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Cerevel Therapeutics Holdings, Inc.
CIK 0001805387
Entity typeother
Related Parties
1- filerCIK 0001744627
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 5:11 PM ET
- Size
- 5.1 KB